Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v2.4.0.6
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Revenues $ 20 $ 57
Cost of revenues 13 140
Gross profit (loss) 7 (83)
Operating expenses:    
Selling, general and administrative 661 593
Research and development 515 73
Total operating expenses 1,176 666
Loss from continuing operations (1,169) (749)
Other income (expense):    
Interest expense (116) (46)
Foreign currency transaction gains (losses) 13  
Financing costs associated with convertible notes   (530)
Change in fair value of warrant liabilities (3,107) (1,476)
Change in fair value of convertible notes (2,400) (2,218)
Total other expense (5,610) (4,270)
Net loss from continuing operations before income taxes (6,779) (5,019)
Benefit for income taxes from continuing operations   492
Net loss from continuing operations, net of income taxes (6,779) (4,527)
Discontinued operations:    
Income from discontinued operations, net of income taxes   53
Gain on sale of discontinued operations, net of provision for income taxes of $492   687
Net income from discontinued operations, net of income taxes   740
Net loss $ (6,779) $ (3,787)
Net loss per weighted average share, basic and diluted:    
From loss on continuing operations attributable to common stockholders (in dollars per share) $ (0.22) $ (0.16)
From income on discontinued operations (in dollars per share)   $ 0.00
From gain on sale of discontinued operations (in dollars per share)   $ 0.04
Net loss attributable to common stockholders per weighted average share, basic and diluted (in dollars per share) $ (0.22) $ (0.12)
Weighted average shares outstanding:    
Basic (in shares) 30,357 30,351